Relmada Therapeutics Inc. logo

Relmada Therapeutics Inc. (RLMD)

Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
5. 20
+0.02
+0.3861%
$
543.33M Market Cap
- P/E Ratio
- Div Yield
874,052 Volume
- Eps
$ 5.18
Previous Close
Investors:
Add Transaction
Day Range
5.13 5.36
Year Range
0.55 8
Want to track RLMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Relmada Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
504,820 $3.11M $2.52M -$590,334.16 -18.95%
Keebeck Wealth Management
Keebeck Wealth Management Keebeck Wealth Management LLC
13,000 $90,480 $67,275 -$23,205 -25.65%
Rekah Franca
Rekah Franca Catalyst Funds Management Pty Ltd.
34,057 $237,037 $172,328.42 -$64,708.58 -27.3%
Regan O'Neill
Regan O'Neill Burkehill Global Management LP
105,263 $732,630.48 $534,736.04 -$197,894.44 -27.01%
Joseph J. Costigan
Joseph J. Costigan apricus wealth LLC
47,462 $340,785.35 $237,310 -$103,475.35 -30.36%
Kevin Roan
Kevin Roan Stempoint Capita LLP
597,409 $4.16M $2.94M -$1.22M -29.31%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
36 $251 $180 -$71 -28.29%
Ian Jameson
Ian Jameson American Capital Advisory, LLC
1,954 $528 $9,770 $9,242 1,750.38%
Zachary Canonico
Zachary Canonico DIADEMA PARTNERS LP
200,842 $970,066.94 $1.04M $68,286.2 7.04%
Stephen A. Greco
Stephen A. Greco Pandora Wealth Inc.
20,000 $5,400 $103,500 $98,100 1,816.67%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
50,773 $245,233.57 $257,419.11 $12,185.54 4.97%